Study protocol: Evaluation of the 'real-world' Farmers Have Hearts - Cardiovascular Health Program

Prev Med Rep. 2022 Oct 17:30:102010. doi: 10.1016/j.pmedr.2022.102010. eCollection 2022 Dec.

Abstract

Premature cardiovascular disease (CVD) mortality among men represents a public health concern worldwide. In Ireland, male farmers are a 'high-risk' group for CVD mortality compared to normative values for Irish males. Despite this, they are perceived to be a 'hard-to-reach' (HTR) group to engage with health interventions. Primary prevention measures, including health screening and health behavior change interventions, are key strategies in addressing CVD yet often do not reach HTR groups such as male farmers. The Farmers Have Hearts - Cardiovascular Health Program (FHH-CHP) is a unique large-scale (n = 868) workplace health intervention specifically targeted at Irish male livestock farmers. It included a baseline and Week 52 health check and a health behavior change intervention with three delivery methods: 'health coach by phone' and/or mobile (M)-health by text message. The program adopted gender-specific and strengths-based methods to maximize participant engagement. It integrated a multi-actor approach and was trialed in a 'real world' practice outside of confined health care settings. Data collection comprised health check results (baseline, Week 52) and self-report measures (baseline, Week 26, Week 52). The FHH-CHP is the first targeted health intervention adopting gender-specific methods to reach and engage male livestock farmers in their cardiovascular health. Documenting the FHH-CHP study protocol is important therefore and will benefit practitioners attempting to apply gender-specific approaches to engage at-risk and HTR groups of men with targeted health interventions. Meeting men outside of clinical health settings and adopting gender competency standards are needed to address inequities in health outcomes experienced by men.

Keywords: Farmers; Gender-specific methodology; Health behavior change intervention; Study protocol; ‘Real world’ trial; ‘hard-to-reach’ population group.